Peter’s work has focused on methodological issues and on clinical trials and meta-analyses on the management of cardiovascular and musculoskeletal disorders. He has had leading roles in major cardiovascular trials, including FAME 2 and MATRIX, and co-authored several European guidelines on the management of cardiovascular disease and diabetes. He contributed to more than 500 papers and has been recognised as a highly cited researcher by the Institute for Scientific Information since 2015.